First the most common cancers are: Bladder CancerBreast...

First the most common cancers are:

Bladder Cancer

Breast Cancer

Colon and Rectal Cancer

Endometrial Cancer

Kidney Cancer

Leukemia

Liver Cancer

Lung Cancer

Melanoma

Non-Hodgkin Lymphoma

Pancreatic Cancer

Prostate Cancer

Thyroid Cancer

--------------------

Secondly, what are the cancers that Optiscan’s technology [currently ZEISS CONVIVO, Optiscan’s InVivage and FIVE2] can be relevant to in vivo (in the living body) and ex-vivo (outside the living body)?

---

Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Adrenocortical Carcinoma

AIDS-Related Cancers

Kaposi Sarcoma (Soft Tissue Sarcoma)

AIDS-Related Lymphoma (Lymphoma)

Primary CNS Lymphoma (Lymphoma)

Anal Cancer

Astrocytomas, Childhood (Brain Cancer)

Atypical Teratoid/Rhabdoid Tumor, Childhood, Central Nervous System (Brain Cancer)

Basal Cell Carcinoma of the Skin (Skin Cancer)

Bile Duct Cancer

Bladder Cancer

Bone Cancer (includes Ewing Sarcoma and Osteosarcoma and Malignant Fibrous Histiocytoma)

Brain Tumors

Breast Cancer

Bronchial Tumors (Lung Cancer)

Burkitt Lymphoma – (Non-Hodgkin Lymphoma)

Carcinoid Tumor (Gastrointestinal)

Carcinoma of Unknown Primary

Cardiac (Heart) Tumors, Childhood

Central Nervous System

Atypical Teratoid/Rhabdoid Tumor, Childhood (Brain Cancer)

Medulloblastoma and Other CNS Embryonal Tumors, Childhood (Brain Cancer)

Germ Cell Tumor, Childhood (Brain Cancer)

Primary CNS Lymphoma

Cervical Cancer

Cholangiocarcinoma – (Bile Duct Cancer)

Chordoma, Childhood (Bone Cancer)

Chronic Lymphocytic Leukemia (CLL)

Chronic Myelogenous Leukemia (CML)

Chronic Myeloproliferative Neoplasms

Colorectal Cancer

Craniopharyngioma, Childhood (Brain Cancer)

Cutaneous T-Cell Lymphoma - Lymphoma (Mycosis Fungoides and Sézary Syndrome)

Ductal Carcinoma In Situ (DCIS) – (Breast Cancer)

Embryonal Tumors, Medulloblastoma and Other Central Nervous System, Childhood (Brain Cancer)

Endometrial Cancer (Uterine Cancer)

Ependymoma, Childhood (Brain Cancer)

Esophageal Cancer

Esthesioneuroblastoma (Head and Neck Cancer)

Ewing Sarcoma (Bone Cancer)

Extracranial Germ Cell Tumor, Childhood

Extragonadal Germ Cell Tumor

Eye Cancer

Intraocular Melanoma

Retinoblastoma

Fallopian Tube Cancer

Gallbladder Cancer

Gastric (Stomach) Cancer

Gastrointestinal Carcinoid Tumor

Gastrointestinal Stromal Tumors (GIST) (Soft Tissue Sarcoma)

Germ Cell Tumors

Childhood Central Nervous System Germ Cell Tumors (Brain Cancer)

Childhood Extracranial Germ Cell Tumors

Extragonadal Germ Cell Tumors

Ovarian Germ Cell Tumors

Testicular Cancer

Gestational Trophoblastic Disease

Hairy Cell Leukemia

Head and Neck Cancer (we have seen a recent study of this!)

Heart Tumors, Childhood

Hepatocellular (Liver) Cancer

Histiocytosis, Langerhans Cell

Hodgkin Lymphoma

Hypopharyngeal Cancer (Head and Neck Cancer)

Intraocular Melanoma

Islet Cell Tumors, Pancreatic Neuroendocrine Tumors

Kaposi Sarcoma (Soft Tissue Sarcoma)

Kidney (Renal Cell) Cancer

Langerhans Cell Histiocytosis

Laryngeal Cancer (Head and Neck Cancer)

Leukemia

Lip and Oral Cavity Cancer (Head and Neck Cancer)

Liver Cancer

Lung Cancer (Non-Small Cell, Small Cell, Pleuropulmonary Blastoma, and Tracheobronchial Tumor)

Lymphoma

Male Breast Cancer

Melanoma

Melanoma, Intraocular (Eye)

Merkel Cell Carcinoma (Skin Cancer)

Mesothelioma, Malignant

Metastatic Cancer

Metastatic Squamous Neck Cancer with Occult Primary (Head and Neck Cancer)

Midline Tract Carcinoma With NUT Gene Changes

Mouth Cancer (Head and Neck Cancer)

Multiple Endocrine Neoplasia Syndromes

Multiple Myeloma/Plasma Cell Neoplasms

Mycosis Fungoides (Lymphoma)

Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms

Myelogenous Leukemia, Chronic (CML)

Myeloid Leukemia, Acute (AML)

Myeloproliferative Neoplasms, Chronic

Nasal Cavity and Paranasal Sinus Cancer (Head and Neck Cancer)

Nasopharyngeal Cancer (Head and Neck Cancer)

Neuroblastoma

Non-Hodgkin Lymphoma

Non-Small Cell Lung Cancer

Oral Cancer, Lip and Oral Cavity Cancer and Oropharyngeal Cancer (Head and Neck Cancer)

Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment

Ovarian Cancer

Pancreatic Cancer

Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)

Papillomatosis (Childhood Laryngeal)

Paraganglioma

Paranasal Sinus and Nasal Cavity Cancer (Head and Neck Cancer)

Parathyroid Cancer

Penile Cancer

Pharyngeal Cancer (Head and Neck Cancer)

Pheochromocytoma

Pituitary Tumor

Plasma Cell Neoplasm/Multiple Myeloma

Pleuropulmonary Blastoma (Lung Cancer)

Pregnancy and Breast Cancer

Primary Central Nervous System (CNS) Lymphoma

Primary Peritoneal Cancer

Prostate Cancer

Rare Cancers of Childhood

Rectal Cancer

Recurrent Cancer

Renal Cell (Kidney) Cancer

Retinoblastoma

Rhabdomyosarcoma, Childhood (Soft Tissue Sarcoma)

Salivary Gland Cancer (Head and Neck Cancer)

Sarcoma

Childhood Rhabdomyosarcoma (Soft Tissue Sarcoma)

Childhood Vascular Tumors (Soft Tissue Sarcoma)

Ewing Sarcoma (Bone Cancer)

Kaposi Sarcoma (Soft Tissue Sarcoma)

Osteosarcoma (Bone Cancer)

Soft Tissue Sarcoma

Uterine Sarcoma

Sézary Syndrome (Lymphoma)

Skin Cancer

Small Cell Lung Cancer

Small Intestine Cancer

Soft Tissue Sarcoma

Squamous Cell Carcinoma of the Skin - Skin Cancer

Squamous Neck Cancer with Occult Primary, Metastatic (Head and Neck Cancer)

Stomach (Gastric) Cancer

T-Cell Lymphoma, Cutaneous - Lymphoma (Mycosis Fungoides and Sèzary Syndrome)

Testicular Cancer

Throat Cancer (Head and Neck Cancer)

Nasopharyngeal Cancer

Oropharyngeal Cancer

Hypopharyngeal Cancer

Thymoma and Thymic Carcinoma

Thyroid Cancer

Tracheobronchial Tumors (Lung Cancer)

Transitional Cell Cancer of the Renal Pelvis and Ureter (Kidney (Renal Cell) Cancer)

Unknown Primary, Carcinoma of

Ureter and Renal Pelvis, Transitional Cell Cancer (Kidney (Renal Cell) Cancer

Urethral Cancer

Uterine Cancer, Endometrial

Uterine Sarcoma

Vaginal Cancer

Vascular Tumors (Soft Tissue Sarcoma)

Vulvar Cancer

Wilms Tumor and Other Childhood Kidney Tumors

--------------------------------------------------------------------

Finally, what is the percentage of the people with one or more of the above cancers who are aware of Optiscan’s technology?

Answer: NOT VERY MANY